jeudi 29 septembre 2022

FDA Approves ALS Treatment Despite Questions About Effectiveness

The drug is safe, and one trial found it may extend survival and slow paralysis in functions like muscle control and speaking. A larger trial will be completed in 2024.

from NYT > Health https://ift.tt/wbE2m5n
via health&fitness

Aucun commentaire:

Enregistrer un commentaire